JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
Provident Financial Services
PFS
$2.92B
| $11.8M | ﹤0.01% |
816,942
+152,527
| +23% | +$2.04M |
2013 Q2
28 quarters
|
|
1677
PENN Entertainment
PENN
$2.02B
| $11.8M | ﹤0.01% |
386,448
-1,056,228
| -73% | -$24.2M |
2015 Q1
21 quarters
|
|
1678
Veeco
VECO
$3.44B
| $11.8M | ﹤0.01% |
874,404
-11,118
| -1% | -$128K |
2016 Q3
15 quarters
|
|
|
BEAT
1679
DELISTED
BioTelemetry, Inc.
BEAT
| $11.8M | ﹤0.01% |
260,989
-10,978
| -4% | -$492K |
2016 Q3
15 quarters
|
|
|
TWTR
1680
CALL
DELISTED
Twitter, Inc.
TWTR
| $11.8M | ﹤0.01% |
395,800
+89,100
| +29% | +$2.69M |
2014 Q3
23 quarters
|
|
|
PRAH
1681
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.8M | ﹤0.01% |
121,148
-89,588
| -43% | -$8.34M |
2016 Q1
17 quarters
|
|
1682
ScottsMiracle-Gro
SMG
$2.86B
| $11.8M | ﹤0.01% |
87,597
-877
| -1% | -$113K |
2013 Q2
28 quarters
|
|
1683
The Ensign Group
ENSG
$10.1B
| $11.8M | ﹤0.01% |
281,073
-36,737
| -12% | -$1.46M |
2013 Q2
28 quarters
|
|
1684
Hancock Whitney
HWC
$5.87B
| $11.8M | ﹤0.01% |
554,613
-78,559
| -12% | -$1.62M |
2013 Q2
28 quarters
|
|
|
CIO
1685
DELISTED
City Office REIT
CIO
| $11.8M | ﹤0.01% |
1,168,252
+93,975
| +9% | +$869K |
2017 Q4
10 quarters
|
|
1686
CALL
Invesco S&P SmallCap Low Volatility ETF
XSLV
$237M
| $11.7M | ﹤0.01% |
+550,000
| New | +$18.3M |
2020 Q2
0 quarters
|
|
1687
PG&E
PCG
$37.1B
| $11.7M | ﹤0.01% |
1,323,320
+1,201,818
| +989% | +$13.1M |
2013 Q2
28 quarters
|
|
|
GOEV
1688
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $11.7M | ﹤0.01% |
2,371
| – | – |
2019 Q4
2 quarters
|
|
|
CXO
1689
DELISTED
CONCHO RESOURCES INC.
CXO
| $11.7M | ﹤0.01% |
227,549
+14,467
| +7% | +$800K |
2013 Q2
28 quarters
|
|
1690
CVR Energy
CVI
$5.72B
| $11.7M | ﹤0.01% |
581,248
+324,871
| +127% | +$6.55M |
2013 Q2
28 quarters
|
|
1691
iShares MSCI USA Momentum Factor ETF
MTUM
$20.7B
| $11.7M | ﹤0.01% |
89,055
+3,618
| +4% | +$438K |
2015 Q1
21 quarters
|
|
1692
Ultragenyx Pharmaceutical
RARE
$1.43B
| $11.7M | ﹤0.01% |
149,107
+37,397
| +33% | +$2.48M |
2014 Q1
25 quarters
|
|
1693
iShares Core S&P US Value ETF
IUSV
$27.4B
| $11.6M | ﹤0.01% |
222,630
+100,184
| +82% | +$5.12M |
2016 Q1
17 quarters
|
|
|
WWE
1694
DELISTED
World Wrestling Entertainment
WWE
| $11.6M | ﹤0.01% |
267,349
-34,584
| -11% | -$1.48M |
2016 Q4
14 quarters
|
|
1695
CALL
Vertex Pharmaceuticals
VRTX
$128B
| $11.6M | ﹤0.01% |
40,000
-44,800
| -53% | -$12.1M |
2017 Q3
11 quarters
|
|
1696
Center Bancorp
CNOB
$1.54B
| $11.6M | ﹤0.01% |
719,608
+104,178
| +17% | +$1.49M |
2017 Q3
11 quarters
|
|
|
JKS
1697
JinkoSolar
JKS
$482M
| $11.6M | ﹤0.01% |
654,282
+187,667
| +40% | +$3.01M |
2019 Q4
2 quarters
|
|
|
BLUE
1698
DELISTED
bluebird bio
BLUE
| $11.6M | ﹤0.01% |
14,624
+3,678
| +34% | +$2.77M |
2014 Q3
23 quarters
|
|
1699
Advanced Energy
AEIS
$11.9B
| $11.6M | ﹤0.01% |
170,439
+6,801
| +4% | +$405K |
2013 Q2
28 quarters
|
|
1700
PUT
Stryker
SYK
$109B
| $11.6M | ﹤0.01% |
+64,100
| New | +$11.8M |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.